130 related articles for article (PubMed ID: 10424746)
1. p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome.
Sáez A; Sánchez E; Sánchez-Beato M; Cruz MA; Chacón I; Muñoz E; Camacho FI; Martínez-Montero JC; Mollejo M; García JF; Piris MA
Br J Cancer; 1999 Jul; 80(9):1427-34. PubMed ID: 10424746
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.
Sánchez-Beato M; Sáez AI; Martínez-Montero JC; Sol Mateo M; Sánchez-Verde L; Villuendas R; Troncone G; Piris MA
Am J Pathol; 1997 Jul; 151(1):151-60. PubMed ID: 9212741
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
Møller MB; Nielsen O; Pedersen NT
Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma.
Seki R; Okamura T; Koga H; Yakushiji K; Hashiguchi M; Yoshimoto K; Ogata H; Imamura R; Nakashima Y; Kage M; Ueno T; Sata M
Am J Hematol; 2003 Aug; 73(4):230-5. PubMed ID: 12879424
[TBL] [Abstract][Full Text] [Related]
7. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Cheng JD; Werness BA; Babb JS; Meropol NJ
Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
10. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
[TBL] [Abstract][Full Text] [Related]
11. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
Filipits M; Jaeger U; Pohl G; Stranzl T; Simonitsch I; Kaider A; Skrabs C; Pirker R
Clin Cancer Res; 2002 Mar; 8(3):729-33. PubMed ID: 11895902
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
[TBL] [Abstract][Full Text] [Related]
14. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
[TBL] [Abstract][Full Text] [Related]
15. Expressions of the CIP/KIP family of CDK inhibitor proteins in primary intestinal large B-cell lymphomas: correlation with clinical outcomes.
Go JH
Pathol Res Pract; 2002; 198(11):741-6. PubMed ID: 12530577
[TBL] [Abstract][Full Text] [Related]
16. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
17. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]